JPRN-UMIN000005012Completed未知
Evaulation of the clinical efficacy and safety of the combined administration of Imidafenacin and Tamsulosin in BPH patients (in which OAB symptoms remain) who did not respond to alpha-1 blocker monotherapy. - Addition Study
Department of Urology, University of Yamanashi, School of Medicine0 sites300 target enrollmentStarted: February 4, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 50years-old to ot applicable (—)
- Sex
- Male
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1)Patients who have administered prohibited substances or who have administered prohibited therapy in the 8 weeks prior to the 1st period (2)Patients who changed the dosage or usage of a restricted medicine in the specified period before the 1st period (3)Patients with anuresis (4)Patients with prostate cancer, neurogenic bladder, urethra stricture, chronic prostatitis, symptomatic urinary tract infection, urinary tract stones and interstitial cystitis (5)Patients with serious cardiac disorder, serious liver dysfunction and serious kidney dysfunction (6)Patients with orthostatic hypotension (7)Patients with pyloristenosis,constriction of dodecadactylon, construction of enteron and adynamic ileus (8)Patients with deterioration of enterokinesis (9)Patients with angle-closure glaucoma (10) Patients with myasthenia gravis. (11) Patients in which it has been confirmed that Qmax is less than 5mL/s. (12)Patients with Polyuria. (13)Any other patients who are regarded as unsuitable for this study by the investigator
Investigators
Similar Trials
Active, not recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.MedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2020-004891-16-LVInstitut de Recherches Internationales Servier968
Recruiting
Not Applicable
Evaluation of the clinical efficacy and safety of fluticasone propionate/ formoterol fumarate combination (FFC) for the treatment of bronchial asthma-with and without use of an inhalation deviceBronchial AsthmaJPRN-UMIN000015602Kinki university Department of respiratory medicine and allergology50
Active, not recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.MedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2020-004891-16-CZInstitut de Recherches Internationales Servier968
Active, not recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.MedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2020-004891-16-PLInstitut de Recherches Internationales Servier968
Active, not recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.MedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2020-004891-16-HUInstitut de Recherches Internationales Servier968